In hepatocellular carcinoma, ARID1A demonstrated a higher expression in primary tumors than in metastatic tumors, which suggests that ARID1A expression may be decreased after the initiation of oncogenesis [51]. Here, ARID1A is linked to hepatocellular carcinoma.